Brain Targeting of siRNA via Intranasal Pathway

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|21|31|4606-4613

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.21, Iss.31, 2015-09, pp. : 4606-8

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Intranasal Drug Delivery for Brain Targeting

By  

Current Drug Delivery, Vol. 2, Iss. 2, 2005-01 ,pp. : 165-175

Bentham Science Publishers

Access to resources Recommend Favorite

A Dual Targeting Drug Delivery System for Penetrating Blood-Brain Barrier and Selectively Delivering siRNA to Neurons for Alzheimer’s Disease Treatment

By  

Current Pharmaceutical Biotechnology, Vol. 18, Iss. 14, 2018-04 ,pp. : 1124-1131

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting the Lung Using siRNA and Antisense Based Oligonucleotides

By  

Current Pharmaceutical Design, Vol. 14, Iss. 34, 2008-12 ,pp. : 3620-3627

Bentham Science Publishers

Access to resources Recommend Favorite

Delivery of cefotaxime to the brain via intranasal administration

By Manda Prashanth   Hargett Jamie K.   Kiran Vaka Siva Ram   Repka Michael A.   Narasimha Murthy S.  

Drug Development and Industrial Pharmacy, Vol. 37, Iss. 11, 2011-11 ,pp. : 1306-1310

Informa Healthcare

Access to resources Recommend Favorite

RNAi and siRNA

By Jain KK  

Pharmacogenomics, Vol. 5, Iss. 3, 2004-04 ,pp. : 239-242

Future Medicine

Access to resources Recommend Favorite